Traditional Chinese medicine Lianhuaqingwen into the diagnosis and treatment of influenza
-
Last Update: 2018-01-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
At present, China is in the season of high incidence of influenza The number of reported cases in winter 2017-2018 is significantly higher than that in the same period of previous years In order to effectively respond to the influenza epidemic and ensure the safety of people's health (http://www.chemdrug.com/article/7/), the national health and Family Planning Commission released the influenza diagnosis and treatment plan (2018 version) on January 8, and Lianhua Qingwen capsule became a commonly used Chinese patent medicine in the plan Lianhua Qingwen capsule is an innovative Chinese medicine for the treatment of cold and influenza in China (http://www.chemdrug.com/sell/18/) Around the antiviral effect of Lianhua Qingwen capsule, a large number of scientific researches have been carried out by the Chinese Academy of traditional Chinese medicine, the State Key Laboratory of respiratory diseases of Guangzhou Medical College and other scientific research institutes, which confirmed that Lianhua Qingwen has a good broad-spectrum antiviral effect, and it has strong antiviral effect on influenza A virus (H1N1, H3N2), influenza B virus, avian influenza virus (H5N1, H9N2), adenovirus, herpes virus, etc Inhibit the killing effect Up to now, Lianhua Qingwen has been listed in 15 national epidemic diagnosis and treatment programs, including the diagnosis and treatment program for human infection with influenza A (H1N1) published by the Ministry of health in 2009, the diagnosis and treatment guide for influenza published by the Ministry of health in 2011, and the prevention and treatment program for influenza B (TCM) published by the State Administration of traditional Chinese medicine (http://www.chemdrug.com/) in 2012 Lianhua Qingwen capsule has passed the validation of evidence-based medicine in the treatment of influenza, which is the most scientific and authoritative research method to evaluate the efficacy and safety of drugs (http://www.chemdrug.com/) In 2009, with Beijing You'an Hospital Affiliated to Capital Medical University as the team leader, Hunan Provincial Center for Disease Control and prevention, Henan Province, Shenyang City, Chengdu City, Jinan City infectious disease hospital and other nine domestic hospitals for influenza a treatment, we carried out evidence-based medicine research on the treatment of influenza with traditional Chinese medicine Lianhua Qingwen The research results confirmed that patients with influenza A who took Lianhua Qingwen capsule There is no difference between the time of virus nucleic acid turning negative and that of Tamiflu, which can effectively reduce fever and relieve influenza symptoms such as cough, headache, fatigue and muscle ache The preventive effect of Lianhuaqingwen Capsule on influenza was also verified by practice In 2009, there was an epidemic of influenza aggregation in Dongfang University City, Langfang City, Hebei Province After the outbreak, in addition to the treatment of confirmed patients, close contacts and surrounding healthy people were quickly isolated Close contacts were given Lianhuaqingwen capsule 4 capsules / time, 3 times / day, and the surrounding healthy people were given 2 capsules / time, 3 times / day, for one week During the period from September 3 to September 17, only 5 sporadic cases were confirmed in Langfang City, but none of the key population was seriously endangered by Lianhua Qingwen capsule, which showed the preventive effect of Lianhua Qingwen capsule With good therapeutic effect of cold and influenza, Lianhua Qingwen capsule won the second prize of national science and technology progress in 2011 It has been exported to Hungary, Romania and other foreign markets, and officially entered the FDA (http://www.chemdrug.com/article/11/) phase II clinical, which has been praised by the international medical community and the majority of patients
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.